RECTUM CANCER
Clinical trials for RECTUM CANCER explained in plain language.
Never miss a new study
Get alerted when new RECTUM CANCER trials appear
Sign up with your email to follow new studies for RECTUM CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo tested for Tough-to-Treat colon cancer
Disease control OngoingThis study is testing whether a combination of two drugs, cabozantinib and nivolumab, can help control advanced colorectal cancer that has stopped responding to standard treatments. It will involve about 48 adults whose cancer has spread and is a specific type called microsatelli…
Matched conditions: RECTUM CANCER
Phase: PHASE2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Experimental immune cell therapy tested for tough cancers
Disease control TerminatedThis early-stage study is testing whether immune cells from healthy donors, given along with two other drugs, are safe for people with advanced colorectal, stomach, or hard-to-treat blood cancers. The goal is to see if this combination helps the donor immune cells last longer in …
Matched conditions: RECTUM CANCER
Phase: PHASE1 • Sponsor: David Wald • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC